Circulating Nucleosome Quantification (Nu.Q®) Technology for Monitoring Target Engagement and Adverse Events in Oncology Trials
Join us for a comprehensive webinar featuring experts in epigenetics and assay development, focusing on the scientific foundations and applications of Nucleosome Quantification (Nu.Q®) Technology in the realms of drug development and disease monitoring.
The Translational Utility of Ultrasound and Photoacoustics in Head and Neck Oncology
Dr. Mukund Seshadri presents his interdisciplinary research on developing and evaluating ultrasound and photoacoustic imaging for oral oncology applications, with a focus on the prognostic utility of these methods in assessing treatment responses in head and neck cancer patients.
Assessing Antigen-Specific T Cell Functionality With Dendritic Cell/CD8⁺ T Cell Co-Culture
On December 12, 2023, STEMCELL Technologies' Dr. Catherine Ewen described, in detail, how to set up DC (dendritic cell) and CD8ᐩ T cell co-culture experiments that generate antigen-specific CD8ᐩ T cells, and how to assess CD8ᐩ T cell proliferation, functionality, and killing activity. In this Q&A report, you can read her answers to questions asked by the audience. Answers have been edited for length and/or clarity.
Certis Oncology Solutions, Inc.
Established in 2016, Certis began its journey in precision medicine, helping individual cancer patients and their oncologists determine—with certainty—the best [...]
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8⁺ T Cell Co-culture Experiments
Dr. Catherine Ewen from STEMCELL Technologies answers questions from a recent webinar where she describes how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and activity.
#ExpertAnswers: Lorcan Sherry and Aditya Pratapa on Analyzing Multiplex Immunofluorescence Images
Dr. Lorcan Sherry and Dr. Aditya Pratapa answer questions from a recent webinar where they present a novel workflow for analyzing multiplex immunofluorescence images.
#ExpertAnswers: Conor McCartin on Phage Display Technologies
Dr. Conor McCartin from ProteoGenix answers questions about the utilization of phage display in the development of human antibodies.
#ExpertAnswers: Sarah Klein on SignalStar Multiplex IHC
Dr. Sarah Klein from Cell Signaling Technology answers questions from a recent webinar about accelerating spatial biology discoveries using SignalStar™ Multiplex IHC panels.
#ExpertAnswers: Matt Silva on Cryo-Fluorescence Tomography for Immunotherapy Research
Matthew Silva, PhD, CEO of EMIT Imaging, answers questions from a recent webinar where he highlights the role of cryo-fluorescence tomography in advancing the field of immunotherapy research.
#ExpertAnswers: Victor Arrieta on Anti-PD-1 Immunotherapy for Recurrent Glioblastoma
Dr. Víctor Andrés Arrieta explores how p-ERK activation links to better survival in rGBM patients treated with anti-PD-1 immunotherapy.
#ExpertAnswers: Arutha Kulasinghe on Single-Cell Spatial Phenotyping for Biomarker Discovery
Dr. Arutha Kulasinghe discusses application of single-cell spatial phenotyping for characterizing the tumor microenvironment.
#ExpertAnswers: Mirka Allerding and Anna Sophie Skof on Indivumed Services’ Cell-Free Plasma Biobank
Experts from Indivumed Services answer questions from webinar where they describe the role of longitudinal plasma samples for cancer research.
Overcome the Multiple Challenges of Neutralizing Antibodies in Cancer Therapy Using Innovative Phage Display Technologies
Conor McCartin, PhD, answers questions about the benefits, applications, and process of using innovative phage display technology for cancer therapy and monoclonal antibody development.
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cancer Immunotherapy
In this webinar, Aditya Pratapa and Lorcan Sherry present a new workflow for analyzing multiplex immunoflurescence images.
Assessing Antigen-Specific T-Cell Functionality with Dendritic Cell/CD8⁺ T Cell Co-culture
In this webinar, learn how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and killing activity.
Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in Forecasting Survival and Response to Immune Checkpoint Blockade in Glioblastoma Treatment
Víctor Andrés Arrieta, MD, PhD presents glioblastoma research, covering multiplex immunofluorescence, predictive biomarkers, and ERK1/2 phosphorylation.
Overcome the Multiple Challenges of Neutralizing Antibodies in Cancer Therapy Using Innovative Phage Display Technologies
In this webinar, Dr. Conor McCartin discusses how phage display can be used for human antibody development.
Unlocking Spatial Insights: Accelerate Discoveries 70% Faster with SignalStar™ Multiplex IHC
Join us to learn how to accelerate spatial biology discoveries by 70% with optimized, ready-to-go panels using SignalStar™ Multiplex IHC.
Revolutionizing Immunotherapy Research with 3D, Multiplexed Cryo-fluorescence Tomography
Dr. Matt Silva showcases the power of cryo-fluorescence tomography (CFT) in advancing immunotherapy research.
Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in Forecasting Survival and Response to Immune Checkpoint Blockade in Glioblastoma Treatment
In this webinar, Victor Arrieta highlights the link between p-ERK activation and improved survival in rGBM patients using anti-PD-1 immunotherapy.
Spatial Phenotyping: A Revolutionary Approach to Biomarker Discovery for Cancer Immunotherapy
Dr. Arutha Kulasinghe discusses the potential of single-cell spatial phenotyping in biomarker analysis and how it can be used to characterize tumor microenvironments.
Longitudinal Plasma Samples: Paving the Way for Precision Oncology
In this Q&A Report, experts discuss isolation methods, sample selection, testing techniques, and future applications of cell-free plasma samples for cancer diagnostics and treatment
How to Create CRISPR-Edited T Cells More Efficiently for Tomorrow’s Cell Therapies
Explore future gene-editing trends, CRISPR challenges, and solutions with experts from Artisan Bio and STEMCELL Technologies.
The Next Generation Vevo F2: Better Image Quality For Better Data
Watch this interactive web presentation about the launch of a brand-new version of our flagship Vevo F2 high-to-low frequency ultrasound platform!